Salt, obesity, endothelial function and cardiovascular disease risk study 2007

Phase 4

• Conditions: Obesity; Diet and Nutrition - Obesity

• Registration Number: ACTRN12607000381482
• Lead Sponsor: Commonwealth Scientific Industrial Research Organisation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-07-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 30 overweight and obese men and women (Body Mass Index 27-40kg/m2)• Systolic blood pressure between 130 and 160 mmHg will be selected. • weight stable over the previous 6 months.

Exclusion Criteria

• Known metabolic disease such as liver or kidney disease, hypertension systolic Blood pressure>160 mmHg• Cardiovascular disease• Active weight loss in preceding 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Flow Mediated Dilatation (FMD): Using an ultrasound machine, we will assess the ability of the upper arm artery to become larger after being blocked with an external blood pressure cuff blown up to 250mm Hg for 5 minutes.[Measured at 2 and 4 weeks.]

Secondary Outcome Measures

Name	Time	Method
Blood Pressure[Measured at baseline, 2 weeks and 4 weeks.]